151 related articles for article (PubMed ID: 10768228)
1. [Socioeconomic aspects of urinary calculi and metaphylaxis of urinary calculi].
Strohmaier WL
Urologe A; 2000 Mar; 39(2):166-70. PubMed ID: 10768228
[TBL] [Abstract][Full Text] [Related]
2. [Economic aspects of evidence-based metaphylaxis].
Strohmaier WL
Urologe A; 2006 Nov; 45(11):1406-9. PubMed ID: 17063349
[TBL] [Abstract][Full Text] [Related]
3. Impact of socioeconomic status in etiology and management of urinary stone disease.
Ansari MS; Gupta NP
Urol Int; 2003; 70(4):255-61. PubMed ID: 12776701
[TBL] [Abstract][Full Text] [Related]
4. [Recurrence prevention of urolithiasis with respect to economic aspects].
Siener R; Laube N; Strohmaier WL
Urologe A; 2011 Oct; 50(10):1276, 1278-82. PubMed ID: 21976120
[TBL] [Abstract][Full Text] [Related]
5. Course of calcium stone disease without treatment. What can we expect?
Strohmaier WL
Eur Urol; 2000 Mar; 37(3):339-44. PubMed ID: 10720863
[TBL] [Abstract][Full Text] [Related]
6. When is medical prophylaxis cost-effective for recurrent calcium stones?
Chandhoke PS
J Urol; 2002 Sep; 168(3):937-40. PubMed ID: 12187194
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of medical management strategies for nephrolithiasis.
Lotan Y; Cadeddu JA; Roerhborn CG; Pak CY; Pearle MS
J Urol; 2004 Dec; 172(6 Pt 1):2275-81. PubMed ID: 15538248
[TBL] [Abstract][Full Text] [Related]
8. 5-year-follow-up of patients with clinically insignificant residual fragments after extracorporeal shockwave lithotripsy.
Osman MM; Alfano Y; Kamp S; Haecker A; Alken P; Michel MS; Knoll T
Eur Urol; 2005 Jun; 47(6):860-4. PubMed ID: 15925084
[TBL] [Abstract][Full Text] [Related]
9. Economics of stone disease/treatment.
Strohmaier WL
Arab J Urol; 2012 Sep; 10(3):273-8. PubMed ID: 26558036
[TBL] [Abstract][Full Text] [Related]
10. [Evidence-based pharmacological metaphylaxis of stone disease].
Straub M; Hautmann RE
Urologe A; 2006 Nov; 45(11):1399-400, 1402-5. PubMed ID: 17119896
[TBL] [Abstract][Full Text] [Related]
11. [Current aspects of stone therapy].
Knoll T; Wendt-Nordahl G; Trojan L; Wenke A; Roeder N; Alken P
Aktuelle Urol; 2005 Feb; 36(1):47-54. PubMed ID: 15732004
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline.
Straub M; Strohmaier WL; Berg W; Beck B; Hoppe B; Laube N; Lahme S; Schmidt M; Hesse A; Koehrmann KU
World J Urol; 2005 Nov; 23(5):309-23. PubMed ID: 16315051
[TBL] [Abstract][Full Text] [Related]
13. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.
Skolarikos A; Straub M; Knoll T; Sarica K; Seitz C; Petřík A; Türk C
Eur Urol; 2015 Apr; 67(4):750-63. PubMed ID: 25454613
[TBL] [Abstract][Full Text] [Related]
14. Causes of phosphate stone formation and the importance of metaphylaxis by urinary acidification: a review.
Hesse A; Heimbach D
World J Urol; 1999 Oct; 17(5):308-15. PubMed ID: 10552150
[TBL] [Abstract][Full Text] [Related]
15. [What kind of stone prevention for whom? Risk-adjusted metaphylaxis following urinary stone disease].
Straub M
Urologe A; 2006 Nov; 45(11):1387-8, 1390-1. PubMed ID: 17082926
[TBL] [Abstract][Full Text] [Related]
16. [Current state of metaphylaxis of urinary stones in Russian Federation].
Malkhasyan VA; Gazimiev MA; Martov AG; Gadzhiev NK; Sukhikh SO; Pushkar DY
Urologiia; 2022 Nov; (5):46-52. PubMed ID: 36382817
[TBL] [Abstract][Full Text] [Related]
17. [Adjustment of urine PH as effective tool for successful metaphylaxis of urinary stone disease. phytotherapy].
Saenko VS; Lachinov EL; Zhantlisov DA; Gorbachev MI; Soltanov AA
Urologiia; 2020 Jun; (3):104-110. PubMed ID: 32597596
[TBL] [Abstract][Full Text] [Related]
18. [Metaphylaxis in the first occurrence of urolithiasis].
Kocvara R; Plasgura P; Petrík A; Louzenský G; Bartonícková K
Cas Lek Cesk; 2000 Dec; 139 Suppl 1():16-8. PubMed ID: 11262895
[TBL] [Abstract][Full Text] [Related]
19. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000.
Hesse A; Brändle E; Wilbert D; Köhrmann KU; Alken P
Eur Urol; 2003 Dec; 44(6):709-13. PubMed ID: 14644124
[TBL] [Abstract][Full Text] [Related]
20. [Modern general metaphylaxis of stone disease. New risks, new evidence, new recommendations].
Siener R; Hesse A
Urologe A; 2006 Nov; 45(11):1392, 1394-8. PubMed ID: 17068668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
